Press Releases

Press Releases

    Date Title View
    12/21/12
    Summary ToggleHorizon Pharma to Receive Approval of DUEXIS(R) From the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA)
    12/03/12
    Summary ToggleHorizon Pharma Begins Initial Commercial Launch of RAYOS(R) (prednisone) Delayed-Release Tablets in the United States
    11/13/12
    Summary ToggleHorizon Pharma Announces Third Quarter 2012 Financial Results and Provides Business Update
    11/12/12
    Summary ToggleHorizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Morning Stiffness in Patients With Active Rheumatoid Arthritis
    11/11/12
    Summary ToggleHorizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis
    11/05/12
    Summary ToggleHorizon Pharma Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets to Be Presented at the American College of Rheumatology Annual Meeting
    10/30/12
    Summary ToggleHorizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2012 Financial Results on November 13, 2012
    10/29/12
    Summary ToggleHorizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012
    10/15/12
    Summary ToggleHorizon Pharma Announces the U.S. Patent and Trademark Office Has Issued a Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
    10/01/12
    Summary ToggleHorizon Pharma Announces Completion of Sales Force Expansion
    Displaying 1 - 10 of 38 results